A new anti-cancer strategy targets cell-surface proteins induced by conventional chemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Katie Ris
References
Rougier, P. & Lepere, C. Semin. Oncol. 32, 15–20 (2005).
Decker, S. & Sausville, E.A. Ann. NY Acad. Sci. 1059, 61–69 (2005).
Romond, E.H. et al. N. Engl. J. Med. 353, 1673–1684 (2005).
Adams, G.P. & Weiner, L.M. Nat. Biotechnol. 23, 1147–1157 (2005).
Rubinfeld, B. et al. Nat. Biotechnol. 24, 205–209 (2006).
Quak, J.J. et al. Am. J. Pathol. 136, 191–197 (1990).
de Bree, R., Roos, J.C., Verel, I., van Dongen, G.A. & Snow, G.B. Oral. Dis. 9, 241–248 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lane, D. Designer combination therapy for cancer. Nat Biotechnol 24, 163–164 (2006). https://doi.org/10.1038/nbt0206-163
Issue Date:
DOI: https://doi.org/10.1038/nbt0206-163
- Springer Nature America, Inc.
This article is cited by
-
Combination chemotherapy in rodents: a model for chemotherapy-induced neuropathic pain and pharmacological screening
Metabolic Brain Disease (2023)
-
Cerium oxide nanoparticles-mediated cascade catalytic chemo-photo tumor combination therapy
Nano Research (2022)
-
Rhamnolipid-coated W/O/W double emulsion nanoparticles for efficient delivery of doxorubicin/erlotinib and combination chemotherapy
Journal of Nanobiotechnology (2021)
-
Facile Synthesis of Surfactant-Free Au Decorated Hollow Silica Nanoparticles for Photothermal Applications
Macromolecular Research (2018)
-
Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma
Journal of Nanobiotechnology (2015)